New South Wales Launches $300,000 Campaign to Combat Teen Vaping.

Nov.17.2022
New South Wales Launches $300,000 Campaign to Combat Teen Vaping.
The New South Wales government has launched a $300,000 education campaign to tackle teenage vaping.

The government of New South Wales recently launched an education campaign costing $300,000 aimed at addressing the issue of youth vaping. Acting Chief Health Officer of New South Wales, Marianne Gale, stated that the "core component" of the campaign is the "Know the Facts - Vaping Toolkit", aimed at teachers, parents and students aged 14-17, containing evidence-based resources and educational material.


The objective is to engage young people in conversations about electronic cigarettes and raise awareness about the health risks," Dr. Gale stated. "There is a view that electronic cigarettes are either completely harmless or less harmful than regular cigarettes, but this is not factual.


However, Lucas emphasized that sadly, the opposite is true. "These so-called electronic cigarettes have been greatly exaggerated at best, and at worst, there is no scientific basis. The Australian public - young and old alike - need to have absolute confidence in any health statements on government websites. Unfortunately, this campaign is far from the truth. Instead, it is filled with blatant lies," she said referring to the campaign.


Australia's anti-smoking strategy is ineffective, according to CAPHRA. They suggest that if Australians want to know the truth, they should look to their neighbor across the Tasman Sea, New Zealand, where e-cigarette products are available for adults who hope to quit smoking without a doctor's prescription. "The lies being spread about e-cigarettes in Australia are an egregious misuse of public funds, which should be dedicated to improving Australia's healthcare system," said Lucas.


The situation we are facing is that a chief health officer in Australia is actively telling the public that the dangers of electronic cigarettes are no less than smoking. International research strongly refutes this claim. She is unable to provide any evidence to support her statement, yet Australians continue to receive such expensive but worthless advice. This is a complete shame.


Lucas added that the local approach has evidently failed as the smoking rates have not decreased. "Demanding doctors to prescribe has disappointed 2.3 million Australian smokers, not to mention about 20,000 Australians who die each year due to smoking-related illnesses. Australia's overall smoking rate has barely changed in the past decade, while New Zealand has halved theirs, largely attributed to their smokers being able to access less harmful alternatives in a dignified manner.


Efforts to reduce the harm caused by tobacco have had mixed results, according to the speaker. However, she added that the approach being taken in New Zealand is proving effective. "New Zealand is being transparent with the public and is on track to achieve its smokefree 2025 goal of reducing smoking rates to below 5%. In contrast, health leaders in Australia continue to ban adult sales and devote significant public resources to spreading scare stories about e-cigarettes.


Lucas, an expert on tobacco control, has concluded that Australia's medical model for electronic cigarettes is seriously failing. He suggests that the continued threat and misinformation surrounding e-cigarettes will make it difficult for Australia to achieve its goal of reducing smoking rates to 10%. Lucas states that a new strategy to eradicate tobacco is needed, as the current one is clearly not effective.


Statement:


This article is a compilation of third-party information, intended for internal industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity and accuracy of the article's content. The translation of this article is only intended for internal industry exchange and research purposes.


Due to limitations in the level of translation, the translated article may not fully reflect the original text. Therefore, the original text should be regarded as the authoritative version.


2FIRSTS maintains complete alignment with the Chinese government on any statements and positions related to domestic, Hong Kong, Macau, Taiwan, and international affairs.


The copyright of the compiled information belongs to the original media and author. If there is an infringement, please contact us to request removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

IHit-HyperV Ceramic Atomization Technology Achieves Commercial Maturity, Redefining the New Standard for Visible E-liquid Pod Systems
IHit-HyperV Ceramic Atomization Technology Achieves Commercial Maturity, Redefining the New Standard for Visible E-liquid Pod Systems
At the 2025 CHAMPS Trade Show, iHit Tech (SMISS Group) announced the commercial maturity of its IHit-HyperV ceramic atomization technology. The breakthrough boosts efficiency and flavor performance, setting a new benchmark for visible e-liquid pod systems.
Sep.15
Research Brief | Canadian Study Finds Nickel, Chromium, and Lead Particles in Cannabis Vapes, Some Exceed International Limits
Research Brief | Canadian Study Finds Nickel, Chromium, and Lead Particles in Cannabis Vapes, Some Exceed International Limits
This study, published in Scientific Reports and conducted by a Canadian research team, investigated metal particle contamination in cannabis vape liquids. The analysis of six legal products revealed that all samples contained metals such as aluminum, nickel, and zinc, with some concentrations exceeding pharmacopeial limits. Simulated vaping experiments showed that these particles can enter the aerosol and be inhaled, with the primary source being the hardware components of the devices. The autho
Sep.03 by 2FIRSTS.ai
Glo Hilo goes nationwide in Japan, 2Firsts tracks market feedback: flavor and appearance are well-received, but price is a point of contention.
Glo Hilo goes nationwide in Japan, 2Firsts tracks market feedback: flavor and appearance are well-received, but price is a point of contention.
BAT Japan launched a new heated tobacco product, glo Hilo, on September 1st. Priced at 3,980 yen, it received positive initial feedback. Users praised its stylish design and better taste and odor control compared to IQOS. The main criticism was a burnt taste on the first puff due to rapid heating.
Sep.02
Belgium to Tighten Tobacco Controls in 2027: Vaping Banned on Café & Restaurant Terraces; Shisha Bars to Close
Belgium to Tighten Tobacco Controls in 2027: Vaping Banned on Café & Restaurant Terraces; Shisha Bars to Close
The Belgian government has announced a new round of tobacco-control measures: starting January 1, 2027, smoking traditional tobacco and using e-cigarettes will be banned on café and restaurant terraces, all designated indoor smoking rooms will be abolished, and shisha bars will be closed. The ban applies to both customers and operators; terraces must display no-smoking signage, and even placing ashtrays on tables will be subject to penalties.
Sep.16 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Ireland implements new regulations banning sale of tobacco products through vending machines​, aims to reduce smoking rate to below 5%​.
Ireland implements new regulations banning sale of tobacco products through vending machines​, aims to reduce smoking rate to below 5%​.
Ireland bans sale of cigarettes, e-cigarettes from vending machines to reduce smoking rates, underage access.
Sep.29 by 2FIRSTS.ai